Department of Medicine, Dunedin School of Medicine, University of Otago, PO Box 56, Dunedin 9054, New Zealand.
Kaupapa Consulting Ltd., 52 Vigor Brown St, Napier 4110, New Zealand.
Prim Care Diabetes. 2022 Apr;16(2):301-306. doi: 10.1016/j.pcd.2021.10.003. Epub 2021 Dec 23.
The aim of this study was to explore the experience and perceptions of a diagnosis of prediabetes among a demographically diverse sample of New Zealanders who had, and had not, regressed to normoglycaemia following participation in a primary care nurse-delivered intervention for 6 months. The sample included Indigenous Māori who have high rates of diabetes and associated co-morbidities.
A purposefully selected sample of 58 people with prediabetes and BMI >25 kg/m, stratified by male/female, Māori/non-Māori, and those who had/had not regressed to normoglycaemia, after completing 6-months of a prediabetes intervention were interviewed. Interviews were audio-recorded and transcribed. Data were analysed by thematic analysis.
Most participants recalled being shocked when told they had prediabetes, but they did not perceive the diagnosis to be a label in a negative sense, and some, described the diagnosis as helpful. Participants appreciated knowing that prediabetes could be reversed, and the opportunity to be able to take supported action and make lifestyle changes through the nurse-delivered prediabetes lifestyle intervention. Participants' clear preference was to take control and make dietary changes, not to take Metformin.
Prediabetes was not considered a negative label, but an opportunity, when coupled with a primary care nurse-delivered dietary intervention.
本研究旨在探讨在参与了为期 6 个月的初级保健护士提供的干预措施后，血糖恢复正常的新西兰人群中，具有不同人口统计学特征的参与者对前驱糖尿病的诊断的体验和看法。该样本包括糖尿病发病率和相关合并症较高的毛利人。
本研究采用目的抽样法，选取了 58 名前驱糖尿病患者和 BMI>25kg/m²的患者作为研究对象，按性别、毛利人/非毛利人、血糖是否恢复正常进行分层，对他们进行了为期 6 个月的前驱糖尿病干预后进行了访谈。访谈进行了录音，并转录为文字。采用主题分析法对数据进行分析。
大多数参与者回忆起被告知患有前驱糖尿病时感到震惊，但他们并不认为诊断是负面的标签，有些参与者认为诊断是有帮助的。参与者赞赏能够知道前驱糖尿病可以逆转，并通过初级保健护士提供的前驱糖尿病生活方式干预有机会采取支持性行动和改变生活方式。参与者明确表示希望控制饮食，而不是服用二甲双胍。
当前驱糖尿病与初级保健护士提供的饮食干预相结合时，前驱糖尿病并不被认为是一个负面标签，而是一个机会。
